{"id":"l-thyroxin","safety":{"commonSideEffects":[{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Anxiety"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Heat intolerance"},{"rate":null,"effect":"Weight loss"}]},"_chembl":{"chemblId":"CHEMBL1624","moleculeType":"Small molecule","molecularWeight":"776.87"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"L-thyroxine (levothyroxine) is converted peripherally to the more active L-triiodothyronine (T3) and acts as a thyroid hormone replacement therapy. It binds to thyroid hormone receptors in target tissues to regulate metabolism, growth, and development. This restores normal thyroid hormone levels in patients with hypothyroidism or thyroid hormone deficiency.","oneSentence":"L-thyroxine is a synthetic thyroid hormone that replaces or supplements endogenous thyroid hormone to restore normal metabolic function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:51:29.047Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypothyroidism"},{"name":"Thyroid hormone replacement after thyroidectomy or radioactive iodine therapy"},{"name":"Thyroid cancer suppression therapy"}]},"trialDetails":[{"nctId":"NCT07424183","phase":"PHASE2","title":"T4/T3 Therapy in Hypothyroidism","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-03","conditions":"Hypothyroidism Primary","enrollment":60},{"nctId":"NCT06073665","phase":"PHASE4","title":"Dosing of LT4 in Older Individuals","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-01-31","conditions":"Hypothyroidism","enrollment":228},{"nctId":"NCT06647602","phase":"","title":"Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-09-01","conditions":"Differentiated Thyroid Cancer, Thyroid Cancer, Levothyroxine","enrollment":40},{"nctId":"NCT07393165","phase":"NA","title":"Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-05-24","conditions":"Levothyroxine, Cardiac Function, Children","enrollment":40},{"nctId":"NCT06790589","phase":"PHASE2","title":"COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-12","conditions":"Advanced Differentiated Thyroid Gland Carcinoma","enrollment":70},{"nctId":"NCT07346157","phase":"PHASE1, PHASE2","title":"Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-01","conditions":"Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent","enrollment":69},{"nctId":"NCT07257250","phase":"","title":"Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2019-01-01","conditions":"Subclinical Hypothyroidism, Infertility, Assisted Reproductive Technology","enrollment":900},{"nctId":"NCT07239674","phase":"PHASE3","title":"Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-11-30","conditions":"Intermediate-to-High Risk Differentiated Thyroid Cancer","enrollment":646},{"nctId":"NCT06652113","phase":"NA","title":"Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-11-15","conditions":"Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies","enrollment":796},{"nctId":"NCT03977207","phase":"NA","title":"A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-07-20","conditions":"Thyroid; Functional Disturbance, Hypothyroidism, Hemodialysis","enrollment":336},{"nctId":"NCT07133295","phase":"","title":"Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients","status":"COMPLETED","sponsor":"Sohag University","startDate":"2021-03-23","conditions":"Hypothyroidism","enrollment":160},{"nctId":"NCT06660823","phase":"PHASE3","title":"Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-30","conditions":"Cardiac Surgery Intensive Care Treatment, Delayed Recovery From Anaesthesia, Euthyroid Sick Syndrome","enrollment":70},{"nctId":"NCT06971965","phase":"NA","title":"Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2025-06-02","conditions":"Thyroid Cancer, Papillary Thyroid Carcinoma","enrollment":578},{"nctId":"NCT04111536","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-03-08","conditions":"Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome","enrollment":28},{"nctId":"NCT04112316","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFrEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-02-11","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Low T3 Syndrome","enrollment":28},{"nctId":"NCT06653907","phase":"PHASE4","title":"Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody","status":"NOT_YET_RECRUITING","sponsor":"Yang ZHANG","startDate":"2024-10-25","conditions":"Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes","enrollment":400},{"nctId":"NCT05918497","phase":"","title":"Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-04-25","conditions":"Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan","enrollment":89},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT04124705","phase":"PHASE2","title":"A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-10-11","conditions":"Hypothyroidism, Thyroid Disease, Euthyroid","enrollment":284},{"nctId":"NCT06346236","phase":"","title":"Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-03-01","conditions":"Transient Hypothyroxinemia of Prematurity","enrollment":373},{"nctId":"NCT02725879","phase":"","title":"FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2015-10","conditions":"Hashimoto Disease","enrollment":90},{"nctId":"NCT05461820","phase":"PHASE4","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-05-01","conditions":"Graves Disease, Relapse, Treatment","enrollment":240},{"nctId":"NCT05316922","phase":"PHASE3","title":"TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients","status":"RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2021-12-13","conditions":"Hypothyroidism; Irradiation","enrollment":68},{"nctId":"NCT06135948","phase":"PHASE4","title":"Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism","status":"COMPLETED","sponsor":"Emirates Health Services (EHS)","startDate":"2022-03-15","conditions":"L-thyroxine","enrollment":103},{"nctId":"NCT04964284","phase":"PHASE3","title":"Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2021-10-06","conditions":"Differentiated Thyroid Cancer","enrollment":328},{"nctId":"NCT06087068","phase":"PHASE2","title":"Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-08-01","conditions":"Thyroid Cancer, Surgery, Recurrence","enrollment":140},{"nctId":"NCT06036576","phase":"PHASE3","title":"Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2022-03-01","conditions":"Recurrent Early Pregnancy Loss, Thyroid Diseases","enrollment":77},{"nctId":"NCT04747275","phase":"PHASE4","title":"Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients","status":"TERMINATED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2021-01-18","conditions":"Hypothyroidism, Trisomy 21","enrollment":6},{"nctId":"NCT02665325","phase":"","title":"Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Inner Mongolia Medical University","startDate":"2016-01","conditions":"Cognitive Impairment","enrollment":100},{"nctId":"NCT02567877","phase":"","title":"Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2016-11","conditions":"Postsurgical Hypothyroidism, Hypothyroidism","enrollment":12},{"nctId":"NCT03926585","phase":"","title":"Variations in the DIO2 and MCT10 Genes and Effect of Triiodothyronine Treatment","status":"COMPLETED","sponsor":"Birte Nygaard","startDate":"2019-04-23","conditions":"Hypothyroidism","enrollment":82},{"nctId":"NCT04354896","phase":"PHASE4","title":"The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-05","conditions":"Subclinical Hypothyroidism, Sarcopenia","enrollment":322},{"nctId":"NCT04868045","phase":"PHASE1","title":"Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer","status":"WITHDRAWN","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-04-27","conditions":"Thyroid Cancer","enrollment":""},{"nctId":"NCT01848171","phase":"PHASE4","title":"Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2013-07","conditions":"Hypothyroidism, Thyroid Diseases, Endocrine System Diseases","enrollment":700},{"nctId":"NCT05017610","phase":"EARLY_PHASE1","title":"Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2021-10-20","conditions":"Recurrent Glioblastoma, Recurrent Gliosarcoma","enrollment":""},{"nctId":"NCT05421468","phase":"NA","title":"Timing of Thyroxine Dose In Ramadan","status":"UNKNOWN","sponsor":"King Abdullah International Medical Research Center","startDate":"2022-03-14","conditions":"Hypothyroidism","enrollment":250},{"nctId":"NCT03787303","phase":"PHASE2","title":"Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma","status":"TERMINATED","sponsor":"Aultman Health Foundation","startDate":"2019-03-01","conditions":"Metastatic Breast Cancer, Thyroid Dysfunction","enrollment":7},{"nctId":"NCT05371262","phase":"PHASE4","title":"Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism","status":"COMPLETED","sponsor":"Federico II University","startDate":"2011-05","conditions":"Congenital Hypothyroidism","enrollment":72},{"nctId":"NCT05247476","phase":"PHASE4","title":"Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.","status":"UNKNOWN","sponsor":"Zhongshan Hospital Xiamen University","startDate":"2021-10-18","conditions":"Thyroid Cancer, Papillary, Hypothyroidism","enrollment":50},{"nctId":"NCT03391154","phase":"PHASE3","title":"Efficacy of Low Dose Levothyroxine During Pregnancy","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-05-01","conditions":"Euthyroid Females","enrollment":180},{"nctId":"NCT02399475","phase":"NA","title":"Mechanistic Study of Subclinical Hypothyroidism In the Elderly","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-01-01","conditions":"Subclinical Hypothyroidism","enrollment":14},{"nctId":"NCT04313101","phase":"","title":"Association Between Thyroid Dysfunction and Intensive Care Unit Acquired Weaknesss","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-02-20","conditions":"Thyroid Abnormalities, ICU Acquired Weakness","enrollment":114},{"nctId":"NCT04178928","phase":"PHASE1, PHASE2","title":"Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-01","conditions":"Subclinical hypothyroïdism","enrollment":40},{"nctId":"NCT01832753","phase":"NA","title":"Treatment Trial of Subclinical Hypothyroidism in Down Syndrome","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2013-01","conditions":"Down Syndrome, Subclinical Hypothyroidism","enrollment":12},{"nctId":"NCT03898622","phase":"PHASE3","title":"Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2018-10-01","conditions":"Chronic Kidney Diseases, Subclinical Hypothyroidism","enrollment":32},{"nctId":"NCT02500342","phase":"PHASE4","title":"Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-01","conditions":"Thyroid Dysfunction, Mental Fatigue, Fatigue","enrollment":276},{"nctId":"NCT03712683","phase":"NA","title":"Thyroxin in Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2016-09-01","conditions":"Sub Clinical Hypothyroidism, Pregnancy Loss","enrollment":168},{"nctId":"NCT01831869","phase":"PHASE4","title":"Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2013-04","conditions":"Hypothyroidism, Thyroid Diseases, Endocrine System Diseases","enrollment":400},{"nctId":"NCT00565864","phase":"PHASE4","title":"Neurocognitive and Metabolic Effects of Mild Hypothyroidism","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-08","conditions":"Hypothyroidism","enrollment":173},{"nctId":"NCT01306227","phase":"PHASE3","title":"L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2006-09-01","conditions":"Hypothyroxinemia","enrollment":50},{"nctId":"NCT01853579","phase":"PHASE4","title":"The TRUST Study - Depression Substudy","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2013-03","conditions":"Subclinical Hypothyroidism, Depression","enrollment":426},{"nctId":"NCT03115515","phase":"NA","title":"Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2011-08","conditions":"Pregnancy Related, Thyroid","enrollment":60},{"nctId":"NCT03096613","phase":"PHASE4","title":"Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2017-04-18","conditions":"Heart Failure, Subclinical Hypothyroidism","enrollment":124},{"nctId":"NCT01465867","phase":"NA","title":"Selenium Supplementation in Pregnancy","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2012-04","conditions":"Pregnancy, Infertility, Auto-immune Thyroiditis","enrollment":56},{"nctId":"NCT03281083","phase":"PHASE2","title":"Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)","status":"TERMINATED","sponsor":"Duke-NUS Graduate Medical School","startDate":"2014-03-28","conditions":"Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2","enrollment":29},{"nctId":"NCT03106935","phase":"EARLY_PHASE1","title":"Recurrent Pregnancy Loss and Thyroid Disease","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2015-07","conditions":"Recurrent Pregnancy Loss","enrollment":300},{"nctId":"NCT01660126","phase":"PHASE4","title":"Thyroid Hormone Replacement for Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2014-05","conditions":"Subclinical Hypothyroidism","enrollment":737},{"nctId":"NCT02832934","phase":"PHASE4","title":"The TRUST Study - CardioVascular Imaging IMT","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-06","conditions":"Thyroid Dysfunction, Atherosclerosis, Heart Failure","enrollment":184},{"nctId":"NCT02832960","phase":"PHASE4","title":"The TRUST Trial - CardioVascular Imaging ECHO","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-06","conditions":"Thyroid Dysfunction, Atherosclerosis, Heart Failure","enrollment":185},{"nctId":"NCT02491008","phase":"PHASE4","title":"Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-01","conditions":"Thyroid Dysfunction, Bone Mineral Density, Osteoporosis","enrollment":145},{"nctId":"NCT02917863","phase":"PHASE4","title":"Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism","status":"UNKNOWN","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2016-05","conditions":"Hypothyroidism","enrollment":70},{"nctId":"NCT01458600","phase":"PHASE4","title":"Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)","status":"COMPLETED","sponsor":"Mikael Lantz","startDate":"2006-09","conditions":"Graves´ Disease","enrollment":65},{"nctId":"NCT02645786","phase":"","title":"Thyrotropin Over-suppression and Heart","status":"COMPLETED","sponsor":"Chuncheon Sacred Heart Hospital","startDate":"2009-09","conditions":"Malignant Neoplasm of Thyroid, Heart Diseases, Thyrotoxicosis on Thyroxine Therapy","enrollment":31},{"nctId":"NCT01647750","phase":"PHASE4","title":"Study of Optimal Replacement of Thyroxine in the Elderly","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2012-08","conditions":"Hypothyroidism","enrollment":48},{"nctId":"NCT02499471","phase":"NA","title":"Brown Adipose Tissue Activity and Thyroid Hormone","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-03","conditions":"Hypothyroidism, Hyperthyroidism, Obesity","enrollment":12},{"nctId":"NCT01916304","phase":"PHASE2","title":"Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation","status":"COMPLETED","sponsor":"Takeda","startDate":"2013-07","conditions":"Hypothyroidism","enrollment":101},{"nctId":"NCT02317926","phase":"NA","title":"Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2015-05","conditions":"Hypothyroidism","enrollment":81},{"nctId":"NCT02094079","phase":"","title":"Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism","status":"COMPLETED","sponsor":"Birte Nygaard","startDate":"2014-03","conditions":"Hypothyroidism","enrollment":80},{"nctId":"NCT00223158","phase":"NA","title":"Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer","status":"COMPLETED","sponsor":"Patrice Perron","startDate":"2003-09","conditions":"Thyroid Cancer","enrollment":70},{"nctId":"NCT01840332","phase":"NA","title":"Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer","status":"COMPLETED","sponsor":"University of Tartu","startDate":"2013-04","conditions":"Thyroid Cancer","enrollment":20},{"nctId":"NCT01769157","phase":"PHASE4","title":"Effects of L-carnitine on Hypothyroidism","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2012-08","conditions":"Hypothyroidism","enrollment":60},{"nctId":"NCT01379170","phase":"PHASE4","title":"Thyroid Study Type 2 Diabetes Mellitus (T2DM)","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2011-06","conditions":"Diabetes, Hypothyroidism","enrollment":17},{"nctId":"NCT00921050","phase":"PHASE2, PHASE3","title":"Subclinical Hypothyroidism and Mind in the Elderly","status":"COMPLETED","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2009-06","conditions":"Subclinical Hypothyroidism","enrollment":70},{"nctId":"NCT01528839","phase":"PHASE2, PHASE3","title":"Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2004-03","conditions":"Bipolar Disorder","enrollment":74},{"nctId":"NCT01486667","phase":"PHASE3","title":"Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP","status":"UNKNOWN","sponsor":"King Saud University","startDate":"2011-10","conditions":"Dyslipidemia","enrollment":200},{"nctId":"NCT00238030","phase":"PHASE1, PHASE2","title":"Thyroxine Replacement in Organ Donors","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2004-12","conditions":"Brain Death","enrollment":34},{"nctId":"NCT00552253","phase":"NA","title":"Levothyroxine Treatment in Thyroid Benign Nodular Goiter","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2007-10","conditions":"Thyroid Nodule","enrollment":10},{"nctId":"NCT01189344","phase":"NA","title":"Levothyroxine (L-T4) Absorption After Bariatric Surgery","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2007-09","conditions":"Morbid Obesity","enrollment":30},{"nctId":"NCT00715572","phase":"NA","title":"Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2002-03","conditions":"Hypothyroidism","enrollment":36},{"nctId":"NCT00524238","phase":"NA","title":"Metabolic Changes in Hypothyroid Patients","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2004-03","conditions":"Hypothyroidism","enrollment":22},{"nctId":"NCT00497575","phase":"","title":"Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"Zhejiang University","startDate":"1999-10","conditions":"Congenital Hypothyroidism, L-Thyroxine, Follow-Up","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":547,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"},{"count":474,"reaction":"NAUSEA"},{"count":408,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":405,"reaction":"FATIGUE"},{"count":398,"reaction":"DYSPNOEA"},{"count":394,"reaction":"DIARRHOEA"},{"count":341,"reaction":"DIZZINESS"},{"count":316,"reaction":"VOMITING"},{"count":269,"reaction":"PYREXIA"},{"count":267,"reaction":"ASTHENIA"}],"_approvalHistory":[],"publicationCount":309,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Euthyrox (Merck)"],"phase":"marketed","status":"active","brandName":"L-thyroxin","genericName":"L-thyroxin","companyName":"University of Tartu","companyId":"university-of-tartu","modality":"Small molecule","firstApprovalDate":"","aiSummary":"L-thyroxine is a synthetic thyroid hormone that replaces or supplements endogenous thyroid hormone to restore normal metabolic function. Used for Hypothyroidism, Thyroid hormone replacement after thyroidectomy or radioactive iodine therapy, Thyroid cancer suppression therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}